Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Negrin

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Current Opinion in Oncology|December 17, 2009
Biology and clinical effects of natural killer cells in allogeneic transplantationJonathan E Benjamin, Saar Gill, Robert S Negrin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responsesSaar Gill, Janelle A Olson, Robert S Negrin
Frontiers in Immunology|August 22, 2017
Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell TransplantationMelissa Mavers, Kristina Maas-Bauer, Robert S Negrin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Role of naturally arising regulatory T cells in hematopoietic cell transplantationVu H Nguyen, Robert Zeiser, Robert S Negrin
Annual Review of Medicine|January 22, 2005
Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid systemJudith A Shizuru, Robert S Negrin, Irving L Weissman
Immunologic Research|May 6, 2014
A killer choice for cancer immunotherapyTobi L Schmidt, Robert S Negrin, Christopher H Contag
Science (New York, N.Y.)|March 25, 2006
Synergistic antitumor effects of immune cell-viral biotherapySteve H Thorne, Robert S Negrin, Christopher H Contag
Current Stem Cell Reports|January 19, 2016
Regulatory T Cell Immunotherapy in Immune-Mediated DiseasesAntonio Pierini, Dominik Schneidawind, Hidekazu Nishikii, et al.
Current Opinion in Immunology|October 31, 2025
Regulatory T cell approaches for graft-versus-host disease preventionCameron S Bader, Everett H Meyer, Robert S Negrin
Methods in Molecular Medicine|August 2, 2007
Methods for imaging cell fates in hematopoiesisJennifer Duda, Mobin Karimi, Robert S Negrin, et al.
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Current Opinion in Oncology|December 17, 2009
Biology and clinical effects of natural killer cells in allogeneic transplantationJonathan E Benjamin, Saar Gill, Robert S Negrin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responsesSaar Gill, Janelle A Olson, Robert S Negrin
Frontiers in Immunology|August 22, 2017
Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell TransplantationMelissa Mavers, Kristina Maas-Bauer, Robert S Negrin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Role of naturally arising regulatory T cells in hematopoietic cell transplantationVu H Nguyen, Robert Zeiser, Robert S Negrin
Annual Review of Medicine|January 22, 2005
Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid systemJudith A Shizuru, Robert S Negrin, Irving L Weissman
Immunologic Research|May 6, 2014
A killer choice for cancer immunotherapyTobi L Schmidt, Robert S Negrin, Christopher H Contag
Science (New York, N.Y.)|March 25, 2006
Synergistic antitumor effects of immune cell-viral biotherapySteve H Thorne, Robert S Negrin, Christopher H Contag
Current Stem Cell Reports|January 19, 2016
Regulatory T Cell Immunotherapy in Immune-Mediated DiseasesAntonio Pierini, Dominik Schneidawind, Hidekazu Nishikii, et al.
Current Opinion in Immunology|October 31, 2025
Regulatory T cell approaches for graft-versus-host disease preventionCameron S Bader, Everett H Meyer, Robert S Negrin
Methods in Molecular Medicine|August 2, 2007
Methods for imaging cell fates in hematopoiesisJennifer Duda, Mobin Karimi, Robert S Negrin, et al.
Pageof 17